Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms

Abstract Background Endovascular aneurysm repair (EVAR) is now considered the preferred treatment modality in most abdominal aortic aneurysm (AAA) patients. Objectives The objective of this study was to quantify and evaluate MMP-2, MMP-9, TIMP-1, and TIMP-2 expression response to EVAR based on ser...

Full description

Saved in:
Bibliographic Details
Main Authors: Túlio Fabiano de Oliveira Leite, Elpidio Ribeiro da Silva, Karoline Gomes, Daniela Pretti da Cunha Tirapelli, Edwaldo Edner Joviliano
Format: Article
Language:English
Published: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2025-05-01
Series:Jornal Vascular Brasileiro
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492025000100312&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849721837262471168
author Túlio Fabiano de Oliveira Leite
Elpidio Ribeiro da Silva
Karoline Gomes
Daniela Pretti da Cunha Tirapelli
Edwaldo Edner Joviliano
author_facet Túlio Fabiano de Oliveira Leite
Elpidio Ribeiro da Silva
Karoline Gomes
Daniela Pretti da Cunha Tirapelli
Edwaldo Edner Joviliano
author_sort Túlio Fabiano de Oliveira Leite
collection DOAJ
description Abstract Background Endovascular aneurysm repair (EVAR) is now considered the preferred treatment modality in most abdominal aortic aneurysm (AAA) patients. Objectives The objective of this study was to quantify and evaluate MMP-2, MMP-9, TIMP-1, and TIMP-2 expression response to EVAR based on serum assays at 6-month follow-up. Methods 47 patients with AAA who underwent EVAR and ten people with no comorbidities were recruited for the study. Plasma levels of MMPs and TIMPs were assayed by ELISA preoperatively and after 6 months in the group submitted to EVAR and only once in the control group. Demographic profiles, clinical follow-up data, and imaging exams with angiotomography performed preoperatively and after 6 months were collected. Results Forty-seven patients with AAA were treated with EVAR. 87.2% of these patients were male and 68.08% were smokers. There were no deaths in the first 30 days. Ten patients (21.27%) had an endoleak during the 6-month postoperative period. Higher MMP and TIMP levels were observed in the AAA patients compared with patients in the control group, although without statistical significance. After EVAR, there were increases in MMP and TIMP levels both in the group with endoleaks and in the group without endoleaks (p<0.05). The variables related to demographic and anatomical data and types of devices used by the patients did not show statistical significance, except for a significant reduction in aneurysmal sac diameter (p<0.05). Conclusions None of the markers assessed showed any association with endoleak status. However, the concentrations of MMPs and TIMPs in circulation increased in all patients after EVAR. Collectively, these findings suggest that the markers assessed have little potential to influence current post-EVAR monitoring practices.
format Article
id doaj-art-d1e31d2feaea4c5c81920174d21e7139
institution DOAJ
issn 1677-7301
language English
publishDate 2025-05-01
publisher Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
record_format Article
series Jornal Vascular Brasileiro
spelling doaj-art-d1e31d2feaea4c5c81920174d21e71392025-08-20T03:11:32ZengSociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)Jornal Vascular Brasileiro1677-73012025-05-012410.1590/1677-5449.202401631Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysmsTúlio Fabiano de Oliveira Leitehttps://orcid.org/0000-0001-9427-5897Elpidio Ribeiro da SilvaKaroline Gomeshttps://orcid.org/0000-0001-6881-0024Daniela Pretti da Cunha Tirapellihttps://orcid.org/0000-0002-1886-4988Edwaldo Edner Jovilianohttps://orcid.org/0000-0001-7237-4771Abstract Background Endovascular aneurysm repair (EVAR) is now considered the preferred treatment modality in most abdominal aortic aneurysm (AAA) patients. Objectives The objective of this study was to quantify and evaluate MMP-2, MMP-9, TIMP-1, and TIMP-2 expression response to EVAR based on serum assays at 6-month follow-up. Methods 47 patients with AAA who underwent EVAR and ten people with no comorbidities were recruited for the study. Plasma levels of MMPs and TIMPs were assayed by ELISA preoperatively and after 6 months in the group submitted to EVAR and only once in the control group. Demographic profiles, clinical follow-up data, and imaging exams with angiotomography performed preoperatively and after 6 months were collected. Results Forty-seven patients with AAA were treated with EVAR. 87.2% of these patients were male and 68.08% were smokers. There were no deaths in the first 30 days. Ten patients (21.27%) had an endoleak during the 6-month postoperative period. Higher MMP and TIMP levels were observed in the AAA patients compared with patients in the control group, although without statistical significance. After EVAR, there were increases in MMP and TIMP levels both in the group with endoleaks and in the group without endoleaks (p<0.05). The variables related to demographic and anatomical data and types of devices used by the patients did not show statistical significance, except for a significant reduction in aneurysmal sac diameter (p<0.05). Conclusions None of the markers assessed showed any association with endoleak status. However, the concentrations of MMPs and TIMPs in circulation increased in all patients after EVAR. Collectively, these findings suggest that the markers assessed have little potential to influence current post-EVAR monitoring practices.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492025000100312&lng=en&tlng=enabdominal aortic aneurysmendovascular aneurysm repairmatrix metalloproteinasetissue inhibitors of metaloproteinasesendoleaks
spellingShingle Túlio Fabiano de Oliveira Leite
Elpidio Ribeiro da Silva
Karoline Gomes
Daniela Pretti da Cunha Tirapelli
Edwaldo Edner Joviliano
Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
Jornal Vascular Brasileiro
abdominal aortic aneurysm
endovascular aneurysm repair
matrix metalloproteinase
tissue inhibitors of metaloproteinases
endoleaks
title Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
title_full Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
title_fullStr Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
title_full_unstemmed Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
title_short Expression of plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with abdominal aortic aneurysms
title_sort expression of plasma levels of mmp 2 mmp 9 timp 1 and timp 2 in patients with abdominal aortic aneurysms
topic abdominal aortic aneurysm
endovascular aneurysm repair
matrix metalloproteinase
tissue inhibitors of metaloproteinases
endoleaks
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492025000100312&lng=en&tlng=en
work_keys_str_mv AT tuliofabianodeoliveiraleite expressionofplasmalevelsofmmp2mmp9timp1andtimp2inpatientswithabdominalaorticaneurysms
AT elpidioribeirodasilva expressionofplasmalevelsofmmp2mmp9timp1andtimp2inpatientswithabdominalaorticaneurysms
AT karolinegomes expressionofplasmalevelsofmmp2mmp9timp1andtimp2inpatientswithabdominalaorticaneurysms
AT danielaprettidacunhatirapelli expressionofplasmalevelsofmmp2mmp9timp1andtimp2inpatientswithabdominalaorticaneurysms
AT edwaldoednerjoviliano expressionofplasmalevelsofmmp2mmp9timp1andtimp2inpatientswithabdominalaorticaneurysms